SPOTLIGHT: AZ wants to sell Seroquel for bipolar use


AstraZeneca has asked the FDA to expand the use of its schizophrenia drug Seroquel to treatment of bipolar disorder. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.